|
"It
has became apparent that in order to substantially impact
the number of patients enrolled in clinical trials, the community
oncologist needed to be included as a partner in the process.
It is well documented that cancer patients want to receive
the best possible care close to home, in their community,
near friends and family"
|
|
-Craig
Henderson, MD
Professor of Medicine, UCSF
President/CEO, Access Oncology
|
More
than 80 percent of all cancer care is now provided at the community
level, as is 60 percent of all clinical cancer research. This significant
demand for community-based cancer-care services continues to grow
and to meet these evolving needs; new models for the delivery of
cancer care are also emerging. With over 400 cancer drugs in the
research pipeline in the US, and the fact that only 3% to 5% of
cancer patients are enrolled in clinical trials, there is an urgent
need to expand clinical trials outside the traditional academic
setting.
Suburban
Hematology-Oncology Associates
is partnering with many research networks, both in Georgia and across
the United States, to continuously enhance the delivery of state-of-the-art
cancer care.
Our
physicians are affiliated with the following entities:
Atlanta Regional
Community Clinical Oncology Program (ARCCOP): The Community
Clinical Oncology Program (CCOP) was initiated by the National
Cancer Institute (NCI) in 1983 to provide community hospitals
access to a wide range of clinical research studies. Prior to this,
a patient had to travel to one of a few select research institutions
in the country or to the NCI itself to receive the newest treatments.
This meant leaving familiar surroundings of home, family and workplace.
As well, oncology physician specialists in your community wanted
to be part of the search for answers to cure cancer and to offer
you the best treatments available. The ARCCOP, on average, has approximately
40-50 clinical trials open.
UCLA/Translational
Oncology Research Institute (TORI):
TORI is a UCLA based Network that consists of investigators located
at various research sites throughout the US and internationally
that collaborate to conduct large-scale studies addressing therapeutics
and cancer pharmaceuticals. The GOP has contracted with TORI to
be a part of and participate in the TORI network.
National Oncology Alliance Online Collaborative
Oncology Group (NOA-OCOG): The NOA-OCOG Research Alliance
brings together a large number of community-based oncologists capable
of participating in clinical trials and matches them to clinical
trials sponsored by biotechnology and pharmaceutical companies.
OCOG is a research organization that facilitates the ability of
private-practice, community-based oncologists to participate in
clinical research studies, with access to novel cancer drugs through
the latest and most pivotal clinical research studies.
|
|
